Loading
Latest filing published 26 Jun 2026 for Stevanato Group S.p.A.. Read the official filing
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
No signal scores available.
William J. Federici, listed as board member, has filed trades across 2 companies (mainly through SEC (Form 4)), most often in Zynerba Pharmaceuticals, Inc. and Stevanato Group S.p.A. We count 6 filings; the first trade dates from 3 August 2021 and the latest from 15 June 2026.
The open-market record consists of 1 sale, with no purchase. The totals exclude 1 filing filed without an amount. Outside the open market, there are 4 share grants. In 2026 alone, the filings show no purchases and 1 sale.
Most recently, on 26 June 2026, the filings show a share grant in Stevanato Group S.p.A. Filings reach the SEC (Form 4) feed a median of 2 days after the trade. The legal deadline for a Form 4 is two business days after the transaction. Sales are harder to read than purchases, since they often meet personal needs such as tax or diversification. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
6 of 6 declarations